Charlie Chan is an Associate in the Hong Kong office of Conyers.

Charlie’s practice encompasses a broad range of corporate and commercial matters, with a focus on capital markets transactions, including initial public offerings and debt securities offerings. He also advises on general corporate matters and banking and finance transactions, including capital reorganisations, loan facilities and restructurings.

Charlie acts for a wide range of international and regional clients on cross-border transactions involving British Virgin Islands, Bermuda and Cayman Islands structures. He has experience advising on equity offerings, including initial public offerings and secondary listings on major exchanges such as the Hong Kong Stock Exchange, Nasdaq and SGX. His debt capital markets work includes secured and unsecured bond issues, tender offers, convertible bonds and guaranteed senior perpetual securities.

Charlie regularly advises international banks, financial institutions, and public and private companies on the offshore legal aspects of cross-border and multi-jurisdictional transactions.

Experience

  • FWD GROUP HOLDINGS LIMITED HK$3.5 billion (US$442 million) IPO and HKEX Main Board listing
  • PC Partner Group Limited secondary listing by way of introduction on the Main Board of the Singapore Exchange Securities Trading Limited
  • InnoCare Pharma Limited pioneering red-chip listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, or SSE STAR Market in the PRC
  • Nanshan Aluminium International Holdings Limited global offering and HKEX Main Board listing

Qualifications

Education

  • University of Technology Sydney, Graduate Certificate in Professional Legal Practice, 2019
  • University of Exeter, LLB, 2016

Bar Admissions

  • British Virgin Islands, Solicitor, 2022
  • England and Wales, Solicitor, 2022 (not currently practising)
  • Bermuda, Registered Associate, 2021
  • New South Wales, Australia, Solicitor, 2019 (not currently practising)

Languages

  • Cantonese
  • English
  • Mandarin